SE‑Cluster

Search

Search markets, companies, evidence, and pages

readymarket review3 sections8 citations

Q2 2026 Healthcare Services & Facilities market review

Healthcare Services & Facilities is steady this window, with 700 buys in the last 3 years vs 771 prior across 391 public acquirers.

Generated May 26, 2026, 10:49 PMSource packet: market reviewSE-Cluster evidence packet

Client preview

Print and copy from the deliverable view.

Market thesis

[1][2]
2 cites
Attractive buyers combine visible acquisition cadence with clear service-line expansion and target sizes that fit their balance sheet.

[1] 10-K· 2026-03-02

FY 2025 strategy language. Consolidation among competitors may make it more difficult for us to retain or increase our customer base, maintain or improve the terms on which we do business with our suppliers, or maintain or increase our profitability.

[2] 10-K· 2026-03-02

FY 2023 strategy language. Our businesses face significant competition in all of the geographic markets in which we operate. In particular geographies or product segments, our competitors may have certain competitive advantages.

Buyer hierarchy

[1][2][3]
3 cites
UNH, AMGN, ABBV, ELV, GILD lead the current buyer hierarchy with 3,333 recorded buys among ranked acquirers.

[1] 10-K· 2026-03-02

FY 2025 strategy language. Consolidation among competitors may make it more difficult for us to retain or increase our customer base, maintain or improve the terms on which we do business with our suppliers, or maintain or increase our profitability.

[2] 10-K· 2026-03-02

FY 2023 strategy language. Our businesses face significant competition in all of the geographic markets in which we operate. In particular geographies or product segments, our competitors may have certain competitive advantages.

[3] 10-K· 2026-03-02

FY 2023 strategy language. Our competitive position may also be adversely affected by significant merger and acquisition activity in the industries in which we operate, among both our competitors and suppliers.

Filing signals

[4][5][6][7]
4 cites
AbbVie Inc.: Spin, divestiture, or carve-out filings point to a very active separation window. Tenet Healthcare Corp.: 485 recorded buyer-side acquisition reference(s); filings read as very active buyer activity. Novartis AG: 43 recorded buyer-side acquisition reference(s); filings read as very active buyer activity. Quest Diagnostics Inc.: 43 recorded buyer-side acquisition reference(s); filings read as very active buyer activity. Centene Corporation: 34 recorded buyer-side acquisition reference(s); filings read as very active buyer activity.

[4] 10-K· 2026-02-20

FY 2022 strategy language. AbbVie's strategy has focused on delivering strong financial results, maximizing the benefits of the Allergan acquisition, advancing and investing in its pipeline and returning value to shareholders

[5] 10-K· 2026-02-20

FY 2022 strategy language. Following the closing of the Allergan acquisition in 2020, AbbVie implemented an integration plan designed to reduce costs, integrate and optimize the combined organization

[6] 10-K· 2026-02-20

FY 2021 strategy language. AbbVie's strategy has focused on delivering strong financial results, maximizing the benefits of the Allergan acquisition, advancing and investing in its pipeline and returning value to shareholders

[7] 10-K· 2026-02-17

FY 2021 strategy language. We continue to focus on opportunities to expand our Ambulatory Care segment through acquisitions, organic growth, construction of new outpatient centers and strategic partnerships.